Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Dec;107(4):1163–1172. doi: 10.1111/j.1476-5381.1992.tb13424.x

Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.

P G Hellewell 1, P J Jose 1, T J Williams 1
PMCID: PMC1907921  PMID: 1281720

Abstract

1. We have examined the mechanisms of local oedema formation in the passive cutaneous anaphylactic (PCA) reaction in the rabbit. 2. IgE-containing antiserum was injected i.d. and allowed to sensitize skin sites for periods up to 240 h. Antigen (bovine gamma globulin) was injected i.d. or i.v. and local oedema formation assessed by the accumulation of i.v. injected 125I-labelled rabbit serum albumin. Potential inhibitors were mixed with antigen prior to i.d. injection or were administered i.v. 3. Maximum oedema formation was observed when a sensitization period of 48-72 h was used. Oedema formation in the PCA reaction was of short duration with a t 1/2 of approximately 15 min. No evidence of late oedema formation (up to 6 h) was found. 4. Local oedema formation in the PCA was reduced by indomethacin suggesting that vasodilator, oedema-potentiating prostaglandins were released. However, it was likely that other vasodilators were also generated. 5. Antihistamines were poor inhibitors of oedema formation as were PAF antagonists, a 5-lipoxygenase inhibitor, a kallikrein inhibitor, a bradykinin antagonist and anti-C5a antibody. 6. Local oedema formation in the PCA was partially reduced by neutrophil depletion and colchicine suggesting that neutrophil-dependent mediators were involved. 7. Exudate fluid from anaphylactic reactions in the rabbit peritoneal cavity contained permeability-increasing activity when injected into rabbit skin. This activity is now being characterized. 8. A vasodilator prostaglandin appears to be released in the rabbit PCA reaction but none of the established permeability-increasing mediators appears to be involved. Thus, there may be novel inflammatory mediators generated in this reaction which may have relevance for human allergic skin diseases.

Full text

PDF
1163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aked D. M., Foster S. J. Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid. Br J Pharmacol. 1987 Nov;92(3):545–552. doi: 10.1111/j.1476-5381.1987.tb11355.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aked D., Foster S. J., Howarth A., McCormick M. E., Potts H. C. The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation. Br J Pharmacol. 1986 Oct;89(2):431–438. doi: 10.1111/j.1476-5381.1986.tb10277.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836. doi: 10.1146/annurev.bi.59.070190.004031. [DOI] [PubMed] [Google Scholar]
  4. BURKE J. F., MILES A. A. The sequence of vascular events in early infective inflammation. J Pathol Bacteriol. 1958 Jul;76(1):1–19. [PubMed] [Google Scholar]
  5. Bauer H., Zvaifler N. J., Robinson J. O. IgE immunoglobulin in the rabbit. The histopathology of the homologous passive cutaneous anaphylaxis reaction. Lab Invest. 1972 Apr;26(4):448–458. [PubMed] [Google Scholar]
  6. Behrens B. L., Clark R. A., Presley D. M., Graves J. P., Feldsien D. C., Larsen G. L. Comparison of the evolving histopathology of early and late cutaneous and asthmatic responses in rabbits after a single antigen challenge. Lab Invest. 1987 Jan;56(1):101–113. [PubMed] [Google Scholar]
  7. Bochner B. S., Charlesworth E. N., Lichtenstein L. M., Derse C. P., Gillis S., Dinarello C. A., Schleimer R. P. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol. 1990 Dec;86(6 Pt 1):830–839. doi: 10.1016/s0091-6749(05)80143-5. [DOI] [PubMed] [Google Scholar]
  8. Buckley T. L., Brain S. D., Collins P. D., Williams T. J. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol. 1991 May 15;146(10):3424–3430. [PubMed] [Google Scholar]
  9. Casals-Stenzel J., Muacevic G., Weber K. H. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther. 1987 Jun;241(3):974–981. [PubMed] [Google Scholar]
  10. Collins P. D., Jose P. J., Williams T. J. The sequential generation of neutrophil chemoattractant proteins in acute inflammation in the rabbit in vivo. Relationship between C5a and proteins with the characteristics of IL-8/neutrophil-activating protein 1. J Immunol. 1991 Jan 15;146(2):677–684. [PubMed] [Google Scholar]
  11. Dolovich J., Hargreave F. E., Chalmers R., Shier K. J., Gauldie J., Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol. 1973 Jul;52(1):38–46. doi: 10.1016/0091-6749(73)90119-x. [DOI] [PubMed] [Google Scholar]
  12. Dor P. J., Vervloet D., Sapene M., Andrac L., Bonerandi J. J., Charpin J. Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80. J Allergy Clin Immunol. 1983 Apr;71(4):363–370. doi: 10.1016/0091-6749(83)90063-5. [DOI] [PubMed] [Google Scholar]
  13. Dorsch W., Reimann H. J., Neuhauser J. Histamine1--histamine2 antagonism: effect of combined clemastine and cimetidine pretreatment on allergen and histamine-induced reactions of the guinea pig lung in vivo and in vitro. Agents Actions. 1982 Apr;12(1-2):113–118. doi: 10.1007/BF01965120. [DOI] [PubMed] [Google Scholar]
  14. Gordon J. R., Galli S. J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 1990 Jul 19;346(6281):274–276. doi: 10.1038/346274a0. [DOI] [PubMed] [Google Scholar]
  15. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  16. Halonen M., Palmer J. D., Lohman I. C., McManus L. M., Pinckard R. N. Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am Rev Respir Dis. 1980 Dec;122(6):915–924. doi: 10.1164/arrd.1980.122.6.915. [DOI] [PubMed] [Google Scholar]
  17. Haslett C., Jose P. J., Giclas P. C., Williams T. J., Henson P. M. Cessation of neutrophil influx in C5a-induced acute experimental arthritis is associated with loss of chemoattractant activity from the joint space. J Immunol. 1989 May 15;142(10):3510–3517. [PubMed] [Google Scholar]
  18. Hellewell P. G., Williams T. J. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. J Immunol. 1986 Jul 1;137(1):302–307. [PubMed] [Google Scholar]
  19. Hellewell P. G., Williams T. J. An anti-inflammatory steroid inhibits tissue sensitization by IgE in vivo. Br J Pharmacol. 1989 Jan;96(1):5–7. doi: 10.1111/j.1476-5381.1989.tb11776.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hellewell P. G., Williams T. J. Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists. Br J Pharmacol. 1989 May;97(1):171–180. doi: 10.1111/j.1476-5381.1989.tb11939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hellewell P. G., Yarwood H., Williams T. J. Characteristics of oedema formation induced by N-formyl-methionyl-leucyl-phenylalanine in rabbit skin. Br J Pharmacol. 1989 May;97(1):181–189. doi: 10.1111/j.1476-5381.1989.tb11940.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Henson P. M., Cochrane C. G. Immunological induction of increased vascular permeability. I. A rabbit passive cutaneous anaphylactic reaction requiring complement, platelets, and neutrophils. J Exp Med. 1969 Jan 1;129(1):153–165. doi: 10.1084/jem.129.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hutchcroft B. J., Moore E. G., Orange R. P. The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis. J Allergy Clin Immunol. 1979 Jun;63(6):376–382. doi: 10.1016/0091-6749(79)90209-4. [DOI] [PubMed] [Google Scholar]
  24. Ishizaka K., Ishizaka T., Hornbrook M. M. A unique rabbit immunoglobulin having homocytotropic antibody activity. Immunochemistry. 1970 Jun;7(6):515–528. doi: 10.1016/0019-2791(70)90273-9. [DOI] [PubMed] [Google Scholar]
  25. Jose P. J., Forrest M. J., Williams T. J. Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay. J Exp Med. 1983 Dec 1;158(6):2177–2182. doi: 10.1084/jem.158.6.2177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kravis T. C., Zvaifler N. J. Alteration of rabbit PCA reaction by drugs known to influence intracellular cyclic AMP. J Immunol. 1974 Jul;113(1):244–250. [PubMed] [Google Scholar]
  27. Kravis T. C., Zvaifler N. J. Characterization of a rabbit homocytotropic antibody responsible for passive cutaneous anaphylactic reactions with a short (4-hour) latent period. Int Arch Allergy Appl Immunol. 1974;46(1):60–71. doi: 10.1159/000231113. [DOI] [PubMed] [Google Scholar]
  28. Lindqvist K. J. A unique class of rabbit immunoglobulins eliciting passive cutaneous anaphylaxis in homologous skin. Immunochemistry. 1968 Nov;5(6):525–542. doi: 10.1016/0019-2791(68)90089-x. [DOI] [PubMed] [Google Scholar]
  29. Lohman I., Halonen M. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit. Am Rev Respir Dis. 1990 Aug;142(2):390–397. doi: 10.1164/ajrccm/142.2.390. [DOI] [PubMed] [Google Scholar]
  30. Needham L., Hellewell P. G., Williams T. J., Gordon J. L. Endothelial functional responses and increased vascular permeability induced by polycations. Lab Invest. 1988 Oct;59(4):538–548. [PubMed] [Google Scholar]
  31. Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617–648. doi: 10.1146/annurev.iy.09.040191.003153. [DOI] [PubMed] [Google Scholar]
  32. Orr F. W., Varani J., Kreutzer D. L., Senior R. M., Ward P. A. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells. Am J Pathol. 1979 Jan;94(1):75–83. [PMC free article] [PubMed] [Google Scholar]
  33. Pienkowski M. M., Adkinson N. F., Jr, Plaut M., Norman P. S., Lichtenstein L. M. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. J Allergy Clin Immunol. 1988 Jul;82(1):95–100. doi: 10.1016/0091-6749(88)90057-7. [DOI] [PubMed] [Google Scholar]
  34. Ponpipom M. M., Hwang S. B., Doebber T. W., Acton J. J., Alberts A. W., Biftu T., Brooker D. R., Bugianesi R. L., Chabala J. C., Gamble N. L. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. Biochem Biophys Res Commun. 1988 Feb 15;150(3):1213–1220. doi: 10.1016/0006-291x(88)90758-9. [DOI] [PubMed] [Google Scholar]
  35. Rampart M., De Smet W., Fiers W., Herman A. G. Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J Exp Med. 1989 Jun 1;169(6):2227–2232. doi: 10.1084/jem.169.6.2227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rampart M., Williams T. J. Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. Am J Pathol. 1986 Jul;124(1):66–73. [PMC free article] [PubMed] [Google Scholar]
  37. Revoltella R., Ovary Z. Preferential production of rabbit reaginic antibodies. Int Arch Allergy Appl Immunol. 1969;36(3):282–289. doi: 10.1159/000230749. [DOI] [PubMed] [Google Scholar]
  38. Roberts N. M., Page C. P., Chung K. F., Barnes P. J. Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects. J Allergy Clin Immunol. 1988 Aug;82(2):236–241. doi: 10.1016/0091-6749(88)91005-6. [DOI] [PubMed] [Google Scholar]
  39. STETSON C. A., Jr Similarities in the mechanisms determining the Arthus and Shwartzman phenomena. J Exp Med. 1951 Oct;94(4):347–358. doi: 10.1084/jem.94.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schoeffter P., Dion R., Godfraind T. Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery. Br J Pharmacol. 1988 Oct;95(2):531–543. doi: 10.1111/j.1476-5381.1988.tb11674.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Solley G. O., Gleich G. J., Jordon R. E., Schroeter A. L. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest. 1976 Aug;58(2):408–420. doi: 10.1172/JCI108485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Steinbuch M., Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys. 1969 Nov;134(2):279–284. doi: 10.1016/0003-9861(69)90285-9. [DOI] [PubMed] [Google Scholar]
  43. Stux S. V., Ovary Z. Heterogeneity of rabbit homologous skin sensitizing antibodies: IgE and a new subclass IgGa. Int Arch Allergy Appl Immunol. 1976;51(3):338–358. doi: 10.1159/000231608. [DOI] [PubMed] [Google Scholar]
  44. Talbot S. F., Atkins P. C., Goetzl E. J., Zweiman B. Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J Clin Invest. 1985 Aug;76(2):650–656. doi: 10.1172/JCI112018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ueno A., Tanaka K., Katori M., Hayashi M., Arai Y. Species difference in increased vascular permeability by synthetic leukotriene C4 and D4. Prostaglandins. 1981 Apr;21(4):637–648. doi: 10.1016/0090-6980(81)90012-5. [DOI] [PubMed] [Google Scholar]
  46. Vavrek R. J., Stewart J. M. Competitive antagonists of bradykinin. Peptides. 1985 Mar-Apr;6(2):161–164. doi: 10.1016/0196-9781(85)90033-6. [DOI] [PubMed] [Google Scholar]
  47. Warren J. S., Mandel D. M., Johnson K. J., Ward P. A. Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat. J Clin Invest. 1989 Feb;83(2):669–678. doi: 10.1172/JCI113931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Watanabe N., Ovary Z. Antigen and antibody detection by in vivo methods; a reevaluation of passive cutaneous anaphylactic reactions. J Immunol Methods. 1977;14(3-4):381–390. doi: 10.1016/0022-1759(77)90149-1. [DOI] [PubMed] [Google Scholar]
  49. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  50. Weg V. B., Watson M. L., Cordeiro R. S., Williams T. J. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Eur J Pharmacol. 1991 Nov 5;204(2):157–163. doi: 10.1016/0014-2999(91)90700-z. [DOI] [PubMed] [Google Scholar]
  51. Williams T. J., Hellewell P. G., Jose P. J. Inflammatory mechanisms in the Arthus reaction. Agents Actions. 1986 Oct;19(1-2):66–72. doi: 10.1007/BF01977260. [DOI] [PubMed] [Google Scholar]
  52. Williams T. J., Jose P. J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med. 1981 Jan 1;153(1):136–153. doi: 10.1084/jem.153.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]
  54. Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977 Dec 8;270(5637):530–532. doi: 10.1038/270530a0. [DOI] [PubMed] [Google Scholar]
  55. Williams T. J. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol. 1979 Mar;65(3):517–524. doi: 10.1111/j.1476-5381.1979.tb07860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zvaifler N. J., Becker E. L. Rabbit anaphylactic antibody. J Exp Med. 1966 May 1;123(5):935–950. doi: 10.1084/jem.123.5.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zvaifler N. J., Robinson J. O. Rabbit homocytotropic antibody. A unique rabbit immunoglobulin analogous to human IgE. J Exp Med. 1969 Oct 1;130(4):907–929. doi: 10.1084/jem.130.4.907. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES